Articles On Polynovo (ASX:PNV)
Title | Source | Codes | Date |
---|---|---|---|
“Your Stock Request” – 15 August 2019
“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o... |
Fairmont Equities | PNV | 5 years ago |
These are the 10 best mid-cap shares over the past year
One way to find stock ideas is to use a screen to look for companies that have performed well over the past year. In theory shares performing well in the mid-cap space should still have plenty of room to grow, while not being so small that... |
Motley Fool | PNV | 5 years ago |
Why the PolyNovo share price surged higher on Thursday
The PolyNovo Ltd (ASX: PNV) share price was amongst the best performers on the All Ordinaries index on Thursday. The medical device company’s shares were up over 10% at one stage before ending the day 9% higher at $1.60. Why did the PolyNo... |
Motley Fool | PNV | 5 years ago |
PolyNovo share price lifts 6% on trading update
The PolyNovo Ltd (ASX:PNV) share price is trading higher today following an announcement from the company. What did PolyNovo announce? Earlier today PolyNovo released a trading update to the market regarding the company’s earnings and sale... |
Motley Fool | PNV | 5 years ago |
Wellcom share price shoots 28% higher on $265.8 million takeover offer
The best performer on the All Ordinaries index on Thursday has been the Wellcom Group Limited (ASX: WLL) share price. In late morning trade the Australian production and content management company’s shares are up over 28% to $6.76. Why is... |
Motley Fool | PNV | 5 years ago |
This is how ETFs are rewiring the ASX & could make or break your returns
The Pro Medicus Limited (ASX: PME) share price hit a record high of $30.28 this morning despite it being labelled a ‘speculative bubble’ by high profile funds management team Forager Funds alongside 1o other companies with market values gr... |
Motley Fool | PNV | 5 years ago |
A Look At Four ASX-Listed Biotech Stocks With Significant YTD Returns – PNV, TLX, BOT, CUV
The biotechnology sector is one of those sectors that presents an incredible opportunity for huge returns to investors. This is because the business of curing diseases can be lucrative, and any company with a small market capitalisation can... |
Kalkine Media | PNV | 5 years ago |
High profile fundie warns these 10 ASX shares have “bubble” valuations
A lot of debate has emerged recently over why growth shares have tended to outperform value shares with the low interest rate environment worldwide one obvious reason. As interest or risk free rates on cash or other risk free assets like U... |
Motley Fool | PNV | 5 years ago |
Star Performers Of The Month – RSG, PNV, AGG, GOR And RRL
Buying a piece of ownership in a company, given that the world stock markets are gushing with lucrative options every day, can be a daunting task for the investors. Keeping diversification as the fundamental strategy, allocating some portio... |
Kalkine Media | PNV | 5 years ago |
Dr Boreham’s Crucible: Collingwood supporters rejoice, Orthocell can swiftly fix those missing teeth
Here’s one that investors can really get their teeth into: Orthocell’s (ASX:OCC) regenerative therapy Celgro quickens and improves dental implant procedures and repairs jangled nerves in more ways than one. To the joy of Collingwood support... |
Stockhead | PNV | 5 years ago |
Why the PolyNovo share price has rocketed almost 200% higher in 12 months
The PolyNovo Ltd (ASX: PNV) share price has been amongst the best-performers on the Australian share market over the last 12 months. On Monday the medical device company’s shares hit a multi-year high of $1.59, which stretched their 12-mon... |
Motley Fool | PNV | 5 years ago |
Feeling chubby? Check out these obesity-blasting ASX stocks
Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any... |
Stockhead | PNV | 5 years ago |
Feeling chubby? Check out these obesity-blasting ASX stocks
Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any... |
Stockhead | PNV | 5 years ago |
The Gent Manifesto: My Journey And Investment Process
The Gent's Manifesto: My Journey And Investment Philosophy Ethical Equities Founder, Claude Walker has suggested that I share with readers some background on my investing journey to date. This is my own fault and the just desserts for my h... |
Ethical Equities | PNV | 5 years ago |